Florida Clinical Research Center, LLC
- Advisory Board: AstraZeneca LP; Bristol-Myers Squibb; Eli Lilly and Company; GlaxoSmithKline; Merck & Co., Inc.; Novartis Pharmaceutical Corporation; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Pfizer Inc; Sepracor Inc.; Shionogi Inc.; Shire Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.
- Consultant: Abbott Laboratories; AstraZeneca LP; Bristol-Myers Squibb; Eli Lilly and Company; GlaxoSmithKline; Merck & Co., Inc.; Novartis Pharmaceutical Corporation; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Sepracor Inc.; Shionogi Inc.; Shire Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Targacept
- Research Support: Abbott Laboratories; AstraZeneca LP; Bristol-Myers Squibb; Cephalon, Inc.; Eli Lilly and Company; GlaxoSmithKline; Merck & Co., Inc.; Novartis Pharmaceutical Corporation; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Sepracor Inc.; Shionogi Inc.; Shire Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Targacept
- Speakers Bureau: Abbott Laboratories; AstraZeneca LP; Bristol-Myers Squibb; Eli Lilly and Company; GlaxoSmithKline; Merck & Co., Inc.; Novartis Pharmaceutical Corporation; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Sepracor Inc.; Shire Pharmaceuticals Inc.
- Travel Support to attend this meeting: Shire Pharmaceuticals Inc.